EdgarLookup
8-K XBRL

FORM 8-K

Company
Kiniksa Pharmaceuticals International, plc
Filed
October 28, 2025
Period of Report
October 28, 2025
Accession Number
0001104659-25-102834

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →